Related references
Note: Only part of the references are listed.Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity
Timolaos Rizos et al.
JOURNAL OF STROKE (2022)
Safety and efficacy of endovascular thrombectomy in acute ischemic stroke treated with anticoagulants: a systematic review and meta-analysis
Jia-Hung Chen et al.
THROMBOSIS JOURNAL (2022)
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Jan Steffel et al.
EUROPACE (2021)
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
Shin-Yi Lin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Using the PCI-IS Method to Simultaneously Estimate Blood Volume and Quantify Nonvitamin K Antagonist Oral Anticoagulant Concentrations in Dried Blood Spots
Ren-Shiang Jhang et al.
ANALYTICAL CHEMISTRY (2020)
Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke
Yo Han Jung et al.
STROKE (2020)
Cerebral Ischemia in Patients on Direct Oral Anticoagulants Plasma Levels Are Associated With Stroke Severity
Kosmas Macha et al.
STROKE (2019)
Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke
Armin Marsch et al.
CEREBROVASCULAR DISEASES (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality
Taku Inohara et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants
S. Testa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation
Ying Xian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Complexity of Heart Rate Variability Can Predict Stroke-In-Evolution in Acute Ischemic Stroke Patients
Chih-Hao Chen et al.
SCIENTIFIC REPORTS (2015)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Defining hematoma expansion in intracerebral hemorrhage Relationship with patient outcomes
D. Dowlatshahi et al.
NEUROLOGY (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Definition and Evaluation of Transient Ischemic Attack A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.
J. Donald Easton et al.
STROKE (2009)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Share Paper
